Your browser doesn't support javascript.
loading
Ocular sarcoidosis in adults and children: update on clinical manifestation and diagnosis.
Bazewicz, Magdalena; Heissigerova, Jarmila; Pavesio, Carlos; Willermain, François; Skrzypecki, Janusz.
Afiliação
  • Bazewicz M; Department of Ophthalmology, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium. magdalena.bazewicz@stpierre-bru.be.
  • Heissigerova J; Department of Ophthalmology, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium. magdalena.bazewicz@stpierre-bru.be.
  • Pavesio C; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Willermain F; Uveitis Service, Moorfields Eye Hospital, National Health Service Foundation Trust London, London, UK.
  • Skrzypecki J; University College London, London, UK.
J Ophthalmic Inflamm Infect ; 13(1): 41, 2023 Sep 18.
Article em En | MEDLINE | ID: mdl-37721575
ABSTRACT
Sarcoidosis-associated uveitis, is the predominant ocular sarcoidosis presentation, which affects both adults and children. For adults, international ocular sarcoidosis criteria (IWOS) and sarcoidosis-associated uveitis criteria (SUN) are defined. However, for children they are not yet established internationally. Due to the specificity of pediatric manifestations of sarcoidosis, this task is even more challenging. In children, sarcoidosis is subdivided into Blau syndrome and early-onset sarcoidosis (BS/EOS) affecting younger children (< 5 years) and the one affecting older children with clinical presentation resembling adults. Differential diagnosis, clinical work-up as well as diagnostic criteria should be adapted to each age group. In this article, we review the clinical manifestation of sarcoidosis-associated uveitis in adults and children and the sensitivity and specificity of various ocular sarcoidosis diagnostic modalities, including chest X-ray and CT, FDG PET-CT, gallium-67 scintigraphy, bronchoalveolar lavage fluid, genetic testing for NOD2 mutations and serum biomarkers, such as ACE, lysozyme and IL2R.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article